{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:31:10Z","timestamp":1791397870982,"version":"4.3.3"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jaad.2013.06.009","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T02:08:56Z","timestamp":1384222136000},"page":"S44-S56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"S1","title":["Management of facial erythema of rosacea: What is the role of topical \u03b1-adrenergic receptor agonist therapy?"],"prefix":"10.1016","volume":"69","author":[{"given":"James Q.","family":"Del Rosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.06.009_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standardized classification system of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib2","first-page":"907","article-title":"Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea I: etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib4","first-page":"16","article-title":"Advances in understanding and managing rosacea part 1: connecting the dots between pathophysiologic mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema","volume":"5","author":"Del Rosso","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib5","first-page":"26","article-title":"Advances in understanding and managing rosacea part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea","volume":"5","author":"Del Rosso","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","volume":"15","author":"Schwab","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib8","first-page":"53","article-title":"Rosacea as a disease of cathelicidins and skin innate immunity","volume":"15","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2013.06.009_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2013.06.009_bib11","first-page":"614","article-title":"Inflammation in rosacea and acne: implications for patient care","volume":"10","author":"Fleischer","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nm0807-904","article-title":"Rosacea: skin innate immunity gone awry?","volume":"13","author":"Bevins","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2013.06.009_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/jidsymp.2011.2","article-title":"Epidermal proteases in the pathogenesis of rosacea","volume":"15","author":"Meyer-Hoffert","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"Rosacea: the cytokine and chemokine network","volume":"15","author":"Gerber","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL-1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"De","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2013.06.009_bib17","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2013.06.009_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1600-0560.2006.00695.x","article-title":"Lymphangiogenesis and angiogenesis in non-phymatous rosacea","volume":"34","author":"Gomaa","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2013.06.009_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jaad.2007.06.009","article-title":"Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea","volume":"57","author":"Guzman-Sanchez","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2005.10.009","article-title":"Videocapillaroscopic alterations in erythematotelangiectatic rosacea","volume":"54","author":"Rosina","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/jid.2008.320","article-title":"Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37","volume":"129","author":"Park","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000235550","article-title":"Tetracycline actions relevant to rosacea treatment","volume":"22","author":"Korting","year":"2009","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.jaad.2013.06.009_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/jidsymp.2011.5","article-title":"The cutaneous vascular system in chronic skin inflammation","volume":"15","author":"Huggenberger","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib24","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.4049\/jimmunol.171.12.6690","article-title":"The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor","volume":"171","author":"Tjabringa","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.06.009_bib25","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.175.7.4662","article-title":"Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37","volume":"175","author":"Tokumaru","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.06.009_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/sder.2001.27553","article-title":"Rosacea: current thoughts on origin","volume":"20","author":"Bamford","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2013.06.009_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archderm.139.11.1479","article-title":"Modern aspects of cutaneous neurogenic inflammation","volume":"139","author":"Steinhoff","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib28","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2133.2004.05985.x","article-title":"Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis","volume":"150","author":"Dirschka","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib29","first-page":"663","article-title":"The pathophysiology of rosacea","volume":"144","author":"McAleer","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.06.009_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2009.04.024","article-title":"Papulopustular rosacea: prevalence and relationship to photodamage","volume":"63","author":"McAleer","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5021\/ad.2009.21.3.243","article-title":"Clinical evaluation of 168 Korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype","volume":"21","author":"Bae","year":"2009","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2230.2003.01179.x","article-title":"The role of free radicals in the etiopathogenesis of rosacea","volume":"28","author":"Oztas","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaad.2008.10.014","article-title":"Oxidative stress and ferritin expression in the skin of rosacea patients","volume":"60","author":"Tisma","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2010.03825.x","article-title":"Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea","volume":"25","author":"Jang","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.06.009_bib35","first-page":"21","article-title":"The potential role of microorganisms in the development of rosacea","volume":"9","author":"Lazaridou","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2013.06.009_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5021\/ad.2012.24.2.126","article-title":"Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease","volume":"24","author":"Reinholz","year":"2012","journal-title":"Ann Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2013.06.009_bib37","first-page":"28","article-title":"Treating beyond the histology of rosacea","volume":"74","author":"Draelos","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2013.06.009_bib38","first-page":"531","article-title":"American Acne and Rosacea Society rosacea medical management guidelines","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib39","first-page":"97","article-title":"Standard management options for rosacea, part 2: options according to rosacea subtype","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2013.06.009_bib40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib41","first-page":"20","article-title":"Comprehensive medical management of rosacea: an interim study report and literature review","volume":"1","author":"Del Rosso","year":"2008","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib42","first-page":"673","article-title":"Rosacea: a review of current topical, systemic and light based therapies","volume":"144","author":"Kennedy Carney","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.06.009_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14656566.5.1.5","article-title":"Medical treatment of rosacea with emphasis on topical therapies","volume":"5","author":"Del Rosso","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2013.06.009_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00128071-200001030-00007","article-title":"Topical metronidazole: a review of its uses in rosacea","volume":"1","author":"McClellan","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.142.8.1047","article-title":"Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials","volume":"142","author":"Liu","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib46","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase II clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-4362.1998.00275.x","article-title":"Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea","volume":"37","author":"Neumann","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: non-antibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib49","first-page":"664","article-title":"Anti-inflammatory dose doxycycline in the treatment of rosacea","volume":"8","author":"Del Rosso","year":"2009","journal-title":"J Drugs Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2013.06.009_bib50","first-page":"7","article-title":"An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads)","volume":"86","author":"Webster","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2013.06.009_bib51","first-page":"67","article-title":"Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application","volume":"88","author":"Del Rosso","year":"2011","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2013.06.009_bib52","first-page":"607","article-title":"Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea","volume":"9","author":"Del Rosso","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib53","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/jid.2012.14","article-title":"Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin","volume":"132","author":"Kanada","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib54","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1346-8138.2004.tb00567.x","article-title":"The clinical importance of Demodex folliculorum presenting with nonspecific facial signs and symptoms","volume":"31","author":"Karincaoglu","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib55","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1468-3083.2005.01221.x","article-title":"Could matrix metalloproteinase-9 be a link between Demodex folliculorum and rosacea?","volume":"19","author":"Bonamigo","year":"2005","journal-title":"J Eur Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.06.009_bib56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000082564","article-title":"Rosacea: an update","volume":"210","author":"Buechner","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.06.009_bib57","series-title":"Clinical and basic immunology","first-page":"147","article-title":"Photoimmunology","author":"Hansen","year":"2008"},{"key":"10.1016\/j.jaad.2013.06.009_bib58","series-title":"Andrews' diseases of the skin clinical dermatology","first-page":"12","article-title":"Skin: basic structure and function","author":"James","year":"2006"},{"key":"10.1016\/j.jaad.2013.06.009_bib59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/1523-1747.ep12497938","article-title":"Reflex control of the cutaneous vasculature","volume":"69","author":"Rowell","year":"1977","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib60","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1152\/japplphysiol.00407.2010","article-title":"Local thermal control of human cutaneous circulation","volume":"109","author":"Johnson","year":"2010","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jaad.2013.06.009_bib61","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","article-title":"Successful treatment of erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor antagonist, oxymetazoline","volume":"143","author":"Shanler","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/phrs.2001.0857","article-title":"Alpha-adrenoreceptor subtypes","volume":"44","author":"Civantos Calzada","year":"2001","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaad.2013.06.009_bib63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0031-6997(24)01495-9","article-title":"Vascular adrenoreceptors: an update","volume":"53","author":"Guimaraes","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jaad.2013.06.009_bib64","first-page":"H710","article-title":"Different alpha-adrenoreceptor subtypes mediate constriction of arterioles and venules","volume":"270","author":"Leech","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaad.2013.06.009_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/156802607779318172","article-title":"Subclassification and nomenclature of alpha- and beta-adrenoreceptors","volume":"7","author":"Hieble","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jaad.2013.06.009_bib66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3565(24)29397-6","article-title":"Alpha1-adrenergic receptors: new insights and directions","volume":"298","author":"Piascik","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2013.06.009_bib67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1346-8138.2010.00999.x","article-title":"Rosacea (erythematotelangiectatic type) effectively improved by topical xylometazoline","volume":"38","author":"Kim","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib68","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","article-title":"Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment of moderate to severe facial erythema of rosacea: results of two multicenter, randomized and vehicle-controlled studies","volume":"166","author":"Fowler","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib69","first-page":"600","article-title":"Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment","volume":"29","author":"Mark","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2013.06.009_bib70","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2008.08702.x","article-title":"Treatment of rosacea with intense pulsed light: significant treatment and long-lasting results","volume":"159","author":"Papageorgiou","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib71","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1524-4725.2009.01156.x","article-title":"Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea","volume":"35","author":"Neuhaus","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2013.06.009_bib72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10103-002-8263-8","article-title":"Laser treatment of erythema and telangiectasia associated with rosacea","volume":"17","author":"Clark","year":"2002","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jaad.2013.06.009_bib73","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaad.2004.04.010","article-title":"Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life","volume":"51","author":"Tan","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14764170902741311","article-title":"Quality of life of rosacea: pulsed dye laser impact","volume":"11","author":"Menezes","year":"2009","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.jaad.2013.06.009_bib75","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/lsm.10254","article-title":"Flashlamp pulsed dye laser (FPDL) did not cure papulopustular rosacea","volume":"34","author":"Berg","year":"2004","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2013.06.009_bib76","first-page":"650","article-title":"Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies","volume":"12","author":"Fowler","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2013.06.009_bib77","unstructured":"Demirli R, Otto P, Viswanathan R. RBX technology overview, Canfield Imaging Systems, Canfield Scientific, Fairfield, NJ,\u00a0white paper. Available from: URL:http:\/\/www.canfieldscientific.com. Accessed August 25, 2012."},{"key":"10.1016\/j.jaad.2013.06.009_bib78","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213006361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213006361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:29:10Z","timestamp":1759271350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213006361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0190962213006361"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.06.009","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of facial erythema of rosacea: What is the role of topical \u03b1-adrenergic receptor agonist therapy?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}